p42/p44 Mitogen-activated protein kinase signal transduction pathway regulates interleukin-6 expression in PC3 cells, a line of hormone-refractory prostate cancer cells
- PMID: 15659804
- DOI: 10.1196/annals.1329.031
p42/p44 Mitogen-activated protein kinase signal transduction pathway regulates interleukin-6 expression in PC3 cells, a line of hormone-refractory prostate cancer cells
Abstract
The mechanisms that regulate prostate cancer growth and proliferation are not fully understood. IL-6, a multifunctional cytokine, has been shown to play an important role in prostate cancer biology. Functional role of MAP-kinase signal transduction pathways in prostate biology has not been evaluated in detail. In the present study we evaluated the effects of modulation of p42/44 MAP kinase signal transduction pathway on IL-6 expression and secretion by PC3 cells, a line of hormone refractory prostate cancer cells. Results presented, herein, demonstrate that modulation of p42/44 MAP kinase activity results in partial inhibition of synthesis and secretion of IL-6. These data suggest that modulation of p42/p44 may result in regulation of other survival pathways as well.
Similar articles
-
p42/p44 Mitogen-activated protein kinase signal transduction pathway: a novel target for the treatment of hormone-resistant prostate cancer?Ann N Y Acad Sci. 2004 Dec;1030:243-52. doi: 10.1196/annals.1329.030. Ann N Y Acad Sci. 2004. PMID: 15659803 Review.
-
Interleukin-6 and oncostatin M stimulation of proliferation of prostate cancer 22Rv1 cells through the signaling pathways of p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase.Prostate. 2005 Jul 1;64(2):209-16. doi: 10.1002/pros.20235. Prostate. 2005. PMID: 15712220
-
IL-6 and PPARgamma signalling in human PC-3 prostate cancer cells.Anticancer Res. 2009 Jun;29(6):2331-7. Anticancer Res. 2009. PMID: 19528499
-
Dexamethasone suppresses DU145 cell proliferation and cell cycle through inhibition of the extracellular signal-regulated kinase 1/2 pathway and cyclin D1 expression.Asian J Androl. 2008 Jul;10(4):635-41. doi: 10.1111/j.1745-7262.2008.00352.x. Epub 2007 Dec 20. Asian J Androl. 2008. PMID: 18097517
-
Interleukin-6 regulation of prostate cancer cell growth.J Cell Biochem. 2005 Jun 1;95(3):497-505. doi: 10.1002/jcb.20477. J Cell Biochem. 2005. PMID: 15838876 Review.
Cited by
-
RNAi-mediated knockdown of ERK1/2 inhibits cell proliferation and invasion and increases chemosensitivity to cisplatin in human osteosarcoma U2-OS cells in vitro.Int J Oncol. 2012 Apr;40(4):1291-7. doi: 10.3892/ijo.2011.1303. Epub 2011 Dec 15. Int J Oncol. 2012. PMID: 22179790 Free PMC article.
-
Role of p38 MAP Kinase Signal Transduction in Solid Tumors.Genes Cancer. 2013 Sep;4(9-10):342-59. doi: 10.1177/1947601913507951. Genes Cancer. 2013. PMID: 24349632 Free PMC article. Review.
-
Inhibiting the P2X4 Receptor Suppresses Prostate Cancer Growth In Vitro and In Vivo, Suggesting a Potential Clinical Target.Cells. 2020 Nov 20;9(11):2511. doi: 10.3390/cells9112511. Cells. 2020. PMID: 33233569 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical